MPM: AstronauTx, developing treatments for Alzheimer's, raises $59M Series A

The startup works in partnership with UCL and is backed by Novartis and UK gov't fundsIn the United States alone, about 10.7% of people age 65 and older are living with Alzheimer's - the most common form of dementia. That number is projected to grow, as the size of the population in this age group increases. This disease is not just about memory loss: Alzheimer's kills more than breast cancer and prostate cancer combined, according to ... [Read more]